HK1178893A1 - New benzoic pyrrolopyridine derivatives and their use for the treatment of parkinsons disease - Google Patents
New benzoic pyrrolopyridine derivatives and their use for the treatment of parkinsons diseaseInfo
- Publication number
- HK1178893A1 HK1178893A1 HK13105757.7A HK13105757A HK1178893A1 HK 1178893 A1 HK1178893 A1 HK 1178893A1 HK 13105757 A HK13105757 A HK 13105757A HK 1178893 A1 HK1178893 A1 HK 1178893A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- parkinsons disease
- pyrrolopyridine derivatives
- new benzoic
- benzoic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1050113A FR2955110A1 (fr) | 2010-01-08 | 2010-01-08 | Nouveaux derives de type pyrrolopyridine benzoique |
| PCT/FR2011/050023 WO2011083278A1 (fr) | 2010-01-08 | 2011-01-07 | Nouveaux derives de type pyrrolopyridine benzoique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1178893A1 true HK1178893A1 (en) | 2013-09-19 |
Family
ID=42124595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK13105757.7A HK1178893A1 (en) | 2010-01-08 | 2013-05-14 | New benzoic pyrrolopyridine derivatives and their use for the treatment of parkinsons disease |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8546385B2 (xx) |
| EP (1) | EP2521727B1 (xx) |
| JP (1) | JP2013516448A (xx) |
| KR (1) | KR20120123042A (xx) |
| CN (1) | CN102753552A (xx) |
| AR (1) | AR079842A1 (xx) |
| AU (1) | AU2011204518A1 (xx) |
| BR (1) | BR112012016844A2 (xx) |
| CA (1) | CA2785876A1 (xx) |
| DK (1) | DK2521727T3 (xx) |
| EA (1) | EA201290601A1 (xx) |
| ES (1) | ES2478191T3 (xx) |
| FR (1) | FR2955110A1 (xx) |
| HK (1) | HK1178893A1 (xx) |
| MX (1) | MX2012007968A (xx) |
| PL (1) | PL2521727T3 (xx) |
| PT (1) | PT2521727E (xx) |
| SA (1) | SA111320080B1 (xx) |
| TW (1) | TWI473806B (xx) |
| UY (1) | UY33166A (xx) |
| WO (1) | WO2011083278A1 (xx) |
| ZA (1) | ZA201204863B (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102347368B1 (ko) | 2020-11-03 | 2022-01-07 | (주)케이메디켐 | 신규한 아자인돌 유도체, 이의 제조방법 및 이를 포함하는 인지기능 개선용 조성물 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4223560B2 (ja) | 1996-12-13 | 2009-02-12 | アヴェンティス ファーマシューティカルズ インコーポレイテッド | スルホン酸又はスルホニルアミノｎ−（ヘテロアラルキル）アザヘテロシクリルアミド化合物 |
| JP4549534B2 (ja) * | 1998-05-26 | 2010-09-22 | 中外製薬株式会社 | 複素環を有するインドール誘導体及びモノ又はジアザインドール誘導体 |
| GB0119911D0 (en) | 2001-08-15 | 2001-10-10 | Novartis Ag | Organic Compounds |
| GB0303503D0 (en) * | 2003-02-14 | 2003-03-19 | Novartis Ag | Organic compounds |
| JP4845730B2 (ja) | 2003-07-17 | 2011-12-28 | プレキシコン，インコーポレーテッド | Ｐｐａｒ活性化合物 |
| WO2005047268A2 (en) | 2003-11-10 | 2005-05-26 | X-Ceptor Therapeutics, Inc. | Substituted pyrimidine compositions and methods of use |
| FR2890072A1 (fr) * | 2005-09-01 | 2007-03-02 | Fournier S A Sa Lab | Nouveaux composesde pyrrolopyridine |
| FR2903106B1 (fr) | 2006-07-03 | 2010-07-30 | Sanofi Aventis | Utilisations de 2-benzoyl-imidazopyridines en therapeutique |
| FR2903107B1 (fr) | 2006-07-03 | 2008-08-22 | Sanofi Aventis Sa | Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
| FR2903105A1 (fr) | 2006-07-03 | 2008-01-04 | Sanofi Aventis Sa | Derives de 2-benzoyl-imidazopyridines, leur preparation et leur application en therapeutique |
| JP2010519226A (ja) | 2007-02-16 | 2010-06-03 | メモリー・ファーマシューティカルズ・コーポレイション | ５−ｈｔ６受容体親和性を有する６’位置換インドール及びインダゾール誘導体 |
| US20100022581A1 (en) | 2008-07-02 | 2010-01-28 | Memory Pharmaceuticals Corporation | Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity |
-
2010
- 2010-01-08 FR FR1050113A patent/FR2955110A1/fr not_active Withdrawn
-
2011
- 2011-01-05 SA SA111320080A patent/SA111320080B1/ar unknown
- 2011-01-06 AR ARP110100029A patent/AR079842A1/es unknown
- 2011-01-07 CN CN2011800094959A patent/CN102753552A/zh active Pending
- 2011-01-07 UY UY0001033166A patent/UY33166A/es not_active Application Discontinuation
- 2011-01-07 ES ES11704261.4T patent/ES2478191T3/es active Active
- 2011-01-07 EA EA201290601A patent/EA201290601A1/ru unknown
- 2011-01-07 CA CA2785876A patent/CA2785876A1/fr not_active Abandoned
- 2011-01-07 AU AU2011204518A patent/AU2011204518A1/en not_active Abandoned
- 2011-01-07 PL PL11704261T patent/PL2521727T3/pl unknown
- 2011-01-07 JP JP2012547533A patent/JP2013516448A/ja active Pending
- 2011-01-07 EP EP11704261.4A patent/EP2521727B1/fr active Active
- 2011-01-07 WO PCT/FR2011/050023 patent/WO2011083278A1/fr active Application Filing
- 2011-01-07 PT PT117042614T patent/PT2521727E/pt unknown
- 2011-01-07 KR KR1020127017543A patent/KR20120123042A/ko not_active Application Discontinuation
- 2011-01-07 US US13/519,774 patent/US8546385B2/en not_active Expired - Fee Related
- 2011-01-07 BR BR112012016844-4A patent/BR112012016844A2/pt not_active IP Right Cessation
- 2011-01-07 TW TW100100707A patent/TWI473806B/zh not_active IP Right Cessation
- 2011-01-07 MX MX2012007968A patent/MX2012007968A/es not_active Application Discontinuation
- 2011-01-07 DK DK11704261.4T patent/DK2521727T3/da active
-
2012
- 2012-06-29 ZA ZA2012/04863A patent/ZA201204863B/en unknown
-
2013
- 2013-05-14 HK HK13105757.7A patent/HK1178893A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AR079842A1 (es) | 2012-02-22 |
| DK2521727T3 (da) | 2014-06-16 |
| CN102753552A (zh) | 2012-10-24 |
| SA111320080B1 (ar) | 2014-06-23 |
| PT2521727E (pt) | 2014-06-25 |
| FR2955110A1 (fr) | 2011-07-15 |
| UY33166A (es) | 2011-08-31 |
| EA201290601A1 (ru) | 2012-12-28 |
| CA2785876A1 (fr) | 2011-07-14 |
| KR20120123042A (ko) | 2012-11-07 |
| US8546385B2 (en) | 2013-10-01 |
| MX2012007968A (es) | 2012-08-03 |
| JP2013516448A (ja) | 2013-05-13 |
| US20120302560A1 (en) | 2012-11-29 |
| BR112012016844A2 (pt) | 2018-05-08 |
| EP2521727B1 (fr) | 2014-03-19 |
| PL2521727T3 (pl) | 2014-08-29 |
| AU2011204518A1 (en) | 2012-07-26 |
| TW201144307A (en) | 2011-12-16 |
| WO2011083278A1 (fr) | 2011-07-14 |
| ES2478191T3 (es) | 2014-07-18 |
| TWI473806B (zh) | 2015-02-21 |
| ZA201204863B (en) | 2013-09-25 |
| EP2521727A1 (fr) | 2012-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2542086A4 (en) | COMPOUNDS AND ITS THERAPEUTIC USE | |
| IL224544B (en) | Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound | |
| HK1215787A1 (zh) | 用於治療疼痛的藥物組合 | |
| IL223286A0 (en) | Piperidine derivatives and their use for the treatment of metabolic disorders | |
| GB201004020D0 (en) | New therapeutic use | |
| IL218137A0 (en) | Therapeutic aryl-amido-aryl compounds and their use | |
| HK1176936A1 (en) | Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof | |
| IL223721A0 (en) | Heterocyclic compounds, their preparation and their therapeutic application | |
| IL260078B (en) | Therapy used to treat Gaucher disease | |
| GB201011411D0 (en) | Therapeutic compounds and their use | |
| HK1184779A1 (en) | Novel compound and medical use thereof | |
| IL234093A0 (en) | Preparations and dosages for oral administration and their uses for the treatment of Gaucher's disease | |
| PT2555790T (pt) | USO TERAPÊUTICO DA PROTEÍNA DE ß MICROGLOBULINA | |
| HU1000343D0 (en) | Use of kynurenic acid amide derivatives for the treatment of huntington disease | |
| HK1214771A1 (zh) | 用於治療皮膚病的製劑 | |
| HK1178893A1 (en) | New benzoic pyrrolopyridine derivatives and their use for the treatment of parkinsons disease | |
| HK1188565A1 (en) | Diarylpyridazinone derivatives, preparation thereof, and use thereof for the treatment of humans | |
| GB201001383D0 (en) | New compounds and medical uses | |
| GB201001370D0 (en) | New compounds and medical uses | |
| GB201001364D0 (en) | New compounds and medical uses | |
| GB201001376D0 (en) | New compounds and medical uses | |
| GB0913300D0 (en) | Therapeutic compounds and their use | |
| GB201004479D0 (en) | Therapeutic use of new compounds I | |
| GB201018362D0 (en) | Treatment of dupuytren's disease | |
| GB201004480D0 (en) | Therapeutic use of new compounds II |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180107 |